Kindred Biosciences, Inc.

Kindred Biosciences, Inc. (KIN) relating to its proposed acquisition by Elanco Animal Health, Inc. KIN shareholders will receive $9.25 in cash per share they own.

To receive more information regarding the investigation of Kindred Biosciences, Inc. please fill out the form below.